Updated on 2026/06/17

写真a

 
HORIGUCHI Hiroto
 
Organization
School of Medicine Department of Hematology Lecturer
Title
Lecturer
External link

Education

  • Sapporo Medical University   Graduate School of Medicine

    2011.4 - 2015.3

      More details

  • Sapporo Medical University

    2000.4 - 2006.3

      More details

    Country: Japan

    researchmap

Research History

  • Sapporo Medical University   Department of Hematology   Lecturer

    2025.4

      More details

    Country:Japan

    researchmap

  • Sapporo Medical University   Department of Hematology   Assistant Professor

    2023.4 - 2025.3

      More details

    Country:Japan

    researchmap

  • Sapporo Medical University   Department of Hematology

    2019.4 - 2023.3

      More details

  • Boston Children’s Hospital   Division of Hematology/Oncology   Research fellow

    2016.7 - 2019.3

      More details

    Country:United States

    researchmap

Papers

  • Emergence and continuous clonal evolution of a<i> JAK2</i><i> exon</i><i> 12</i>-mutated myeloid clone after treatment for<i> de</i><i> novo</i> acute myeloid leukemia

    Akari Goto, Satoshi Iyama, Masahiro Yoshida, Ayumi Tatekoshi, Hiroto Horiguchi, Masayoshi Kobune

    LEUKEMIA RESEARCH   163   2026.4

     More details

  • Warm Autoimmune Hemolytic Anemia Associated with Pancreatic Adenocarcinoma Showing Ectopic Expression of Band 3 Protein: A Case Report

    Akari Goto, Makoto Yoshida, Ryosei Murai, Hiroto Horiguchi, Satoshi Iyama, Kazuma Ishikawa, Satoshi Takahashi, Kohichi Takada, Masayoshi Kobune

    INTERNAL MEDICINE   2026.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.2169/internalmedicine.6765-25

    Web of Science

    researchmap

  • Disruption of intestinal homeostasis reflected by DAO and microbiota alterations in gvhd post-HSCT.

    Saori Shimoyama-Ibuki, Satoshi Iyama, Shotaro Shirato, Ken Sato, Masahiro Yoshida, Akari Goto, Hiroto Horiguchi, Masayoshi Kobune

    BLOOD   146   2457 - 2458   2025.11

     More details

  • Thrombotic risk with thrombopoietin receptor agonists in immune thrombocytopenia: Real-world evidence from a multicenter Japanese study

    Masahiro Yoshida, Satoshi Iyama, Hiroto Horiguchi, Akari Goto, Makoto Ibata, Tetsuyuki Igarashi, Takeshi Kondo, Yasutaka Kakinoki, Yoshihito Haseyama, Hajime Sakai, Takahiro Nagashima, Shuichi Ota, Junki Inamura, Satoshi Yamamoto, Kentaro Wakasa, Tomoyuki Endo, Masaki Yamamoto, Yuichi Konuma, Shuichiro Takahashi, Naofumi Yamauchi, Katsuya Fujimoto, Masayoshi Kobune

    BLOOD   146   2025.11

     More details

  • Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms

    Kento Ono, Hiroto Horiguchi, Satoshi Iyama, Ken Sato, Saori Ibuki-Shimoyama, Shotaro Shirato, Yusuke Sugama, Akari Goto, Masayoshi Kobune

    INTERNATIONAL JOURNAL OF HEMATOLOGY   122 ( 3 )   400 - 412   2025.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-025-03985-3

    Web of Science

    researchmap

  • Prognostic impact of <i>TET2</i> mutations in patients with acute myeloid leukemia: HM-SCREEN-Japan 01 and 02 study

    Satoshi Iyama, Sunggi Chi, Masashi Idogawa, Takayuki Ikezoe, Kentaro Fukushima, Yoshikazu Utsu, Junya Kanda, Goichi Yoshimoto, Takahiro Kobayashi, Naoko Hosono, Takahiro Yamauchi, Takeshi Kondo, Yukinori Nakamura, Kensuke Kojima, Chikashi Yoshida, Akihiko Gotoh, Kazuhito Yamamoto, Junya Kuroda, Kenji Ishitsuka, Emiko Sakaida, Hiroto Horiguchi, Kohichi Takada, Hirofumi Ohnishi, Masayoshi Kobune, Yosuke Minami

    ANNALS OF HEMATOLOGY   104 ( 1 )   275 - 284   2025.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00277-025-06227-y

    Web of Science

    researchmap

  • Reduced FDG Uptake in the Brain on Baseline 18FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Intravascular Large B-Cell Lymphoma and Advanced-Stage Diffuse Large B-Cell Lymphoma

    Hajime Senjo, Shinpei Harada, Koh Izumiyama, Hideki Goto, Shiro Watanabe, Keito Suto, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Junichi Sugita, Masao Nakagawa, Kenji Hirata, Takuto Miyagishima, Daigo Hashimoto, Takanori Teshima

    BLOOD   144   3096 - 3097   2024.11

     More details

  • Novel method for assessing sinusoidal obstruction syndrome using four-dimensional computed tomography

    Saori Shimoyama-Ibuki, Satoshi Iyama, Yoshiya Ohashi, Kento Ono, Yusuke Sugama, Chisa Fujita, Akari Goto, Hiroto Horiguchi, Akihito Fujimi, Takeo Tanaka, Kohichi Takada, Koh-Ichi Sakata, Masayoshi Kobune

    EJHAEM   5 ( 5 )   1038 - 1042   2024.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/jha2.990

    Web of Science

    researchmap

  • Successful Pregnancy and Fetal Outcomes Following Brentuximab Vedotin for Early Relapsed Classic Hodgkin Lymphoma After Autologous Stem Cell Transplant

    Akari Goto, Chisa Fujita, Hiroto Horiguchi, Satoshi Iyama, Masayoshi Kobune

    CUREUS JOURNAL OF MEDICAL SCIENCE   16 ( 3 )   2024.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.7759/cureus.57291

    Web of Science

    researchmap

  • Adherence of denosumab treatment for low bone mineral density in Japanese people living with HIV: a retrospective observational study

    Yusuke Kunimoto, Ryosuke Matamura, Hiroshi Ikeda, Hiroto Horiguchi, Satoshi Fujii, Masayoshi Kobune, Masahide Fukudo, Takaki Toda

    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES   9 ( 1 )   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1186/s40780-023-00315-9

    Web of Science

    researchmap

  • Baseline 18f-Fluorodeoxyglucose PET/CT Radiomics Predicts Outcome in Newly Diagnosed Intravascular Large B-Cell Lymphoma

    Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Shiro Watanabe, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Daigo Hashimoto, Takanori Teshima

    BLOOD   142   2023.11

     More details

  • Addition of High-Dose Methotrexate to Initial Chemotherapy Improved Treatment Outcome of Patients with Newly Diagnosed Intravascular Large B-Cell Lymphoma: A Multicenter, Retrospective Study

    Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Daigo Hashimoto, Takanori Teshima

    BLOOD   142   2023.11

     More details

  • A Practice-Oriented Genome Profiling Study with the Novel Halo-Shape Annealing and Defer-Ligation Enrichment (HANDLE) System : HM-Screen-JAPAN02

    Hironori Arai, SungGi Chi, Yoshikazu Utsu, Shinichi Masuda, Nobuyuki Aotsuka, Tomoaki Ueda, Kentaro Fukushima, Daisuke Ikeda, Naoko Hosono, Takahiro Yamauchi, Goichi Yoshimoto, Hiroto Horiguchi, Satoshi Iyama, Junya Kanda, Seiichiro Katagiri, Akihiko Gotoh, Daisuke Koyama, Takayuki Ikezoe, Takeshi Kondo, Yukinori Nakamura, Fumiya Ogasawara, Suguru Fukuhara, Koji Izutsu, Nobuhiko Yamauchi, Junichiro Yuda, Yosuke Minami

    BLOOD   140   10722 - 10724   2022.11

     More details

  • Incidentally Detected Complex Karyotypic Abnormalities in the Bone Marrow Provide a Clue to Diagnosing Intravascular Large B-Cell Lymphoma

    Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Takanori Teshima

    BLOOD   140   2022.11

     More details

  • Elevated FDG Uptake in the Lung Is a Characteristic Finding of Intravascular Large B-Cell Lymphoma

    Shinpei Harada, Hideki Goto, Hajime Senjo, Keito Suto, Shiro Watanabe, Yuko Uchiyama, Koh Izumiyama, Masayo Yamamoto, Kazuya Sato, Yasutaka Kakinoki, Tomoyuki Saga, Akio Shigematsu, Hiroto Horiguchi, Mutsumi Takahata, Reiki Ogasawara, Satoshi Yamamoto, Keisuke Yamaguchi, Kentaro Wakasa, Tetsuyuki Igarashi, Yoshihito Haseyama, Shinichi Ito, Katsuya Fujimoto, Junichi Hashiguchi, Masao Nakagawa, Takanori Teshima

    BLOOD   140   6713 - 6714   2022.11

     More details

  • Genomic Analysis of <i>NPM1</i> Mutation and <i>KMT2A</i>(<i>MLL</i>)-Rearrangement/Amplification in Japanese Patients with Acute Myeloid Leukemia: Hematologic Malignancies (HM)-Screen-Japan 01

    Sung Gi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Motoki Eguchi, Takanobu Morishita, Reiki Ogasawara, Takeshi Kondo, Masamitsu Yanada, Kazuhito Yamamoto, Tsutomu Kobayashi, Junya Kuroda, Yoshimasa Kamoda, Kensuke Usuki, Yoshikazu Utsu, Nobuyuki Aotsuka, Makoto Yoshimitsu, Kenji Ishitsuka, Yasuyuki Nagata, Takaaki Ono, Naohito Fujishima, Naoto Takahashi, Hiroto Horiguchi, Satoshi Iyama, Makoto Nakamura, Kensuke Kojima, Kaoru Yamamoto, Yukinori Nakamura, Suguru Fukuhara, Koji Izutsu, Nobuhiko Yamauchi, Junichiro Yuda, Yosuke Minami

    BLOOD   138   2021.11

     More details

  • Possible clinical outcomes using early enteral nutrition in individuals with allogeneic hematopoietic stem cell transplantation: A single-center retrospective study

    Satoshi Iyama, Hiroomi Tatsumi, Tsukasa Shiraishi, Masahiro Yoshida, Ayumi Tatekoshi, Akihito Endo, Taichiro Ishige, Yuh Shiwa, Soushi Ibata, Akari Goto, Kana Nagashima, Hiroto Horiguchi, Chisa Fujita, Hiroshi Ikeda, Kohichi Takada, Takayuki Nobuoka, Yusuke Kamihara, Shohei Kikuchi, Tsutomu Sato, Hirofumi Ohnishi, Shin-ichi Yokota, Masayoshi Kobune

    NUTRITION   83   2021.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.nut.2020.111093

    Web of Science

    researchmap

  • Genetic Features of AML with MLL-Rearrangement and NPM1 Mutation: An Interim-Analysis of HM-Screen-Japan 01

    SungGi Chi, Naoko Hosono, Takahiro Yamauchi, Kentaro Fukushima, Hirohiko Shibayama, Seiichiro Katagiri, Akihiko Gotoh, Motohito Okabe, Takanobu Morishita, Masamitsu Yanada, Kazuhito Yamamoto, Naohito Fujishima, Naoto Takahashi, Reiki Ogasawara, Takeshi Kondo, Yoshikazu Utsu, Nobuyuki Aotsuka, Yoshimasa Kamoda, Kensuke Usuki, Kanenari Takemura, Yasuyuki Nagata, Takaaki Ono, Tsutomu Kobayashi, Junya Kuroda, Hiroto Horiguchi, Satoshi Iyama, Suguru Fukuhara, Koji Izutsu, Makoto Nakamura, Kazuto Togitani, Kensuke Kojima, Kaoru Yamamoto, Yukinori Nakamura, Makoto Yoshimitsu, Kenji Ishitsuka, Kenichi Miyamoto, Yosuke Minami

    BLOOD   136   2020.11

     More details

  • CD34+Positive Myelodysplastic Cells with Ring Sideroblasts or SF3B1 Mutation Produce High Erythroferrone and GDF15

    Hiroto Horiguchi, Masayoshi Kobune, Kento Ono, Saori Shimoyama, Chisa Fujita, Akari Goto, Hiroshi Ikeda, Satoshi Iyama

    BLOOD   136   2020.11

     More details

  • Genomic Analysis of <i>FLT3</i> Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 01

    Kentaro Fukushima, SungGi Chi, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Takanobu Morishita, Masamitsu Yanada, Kazuhito Yamamoto, Naohito Fujishima, Naoto Takahashi, Reiki Ogasawara, Takeshi Kondo, Yoshikazu Utsu, Nobuyuki Aotsuka, Kensuke Usuki, Takaaki Ono, Tsutomu Kobayashi, Junya Kuroda, Hiroto Horiguchi, Satoshi Iyama, Suguru Fukuhara, Koji Izutsu, Makoto Nakamura, Kensuke Kojima, Kenichi Miyamoto, Yosuke Minami

    BLOOD   136   2020.11

     More details

  • Interim Analysis of Hematologic Malignancies (HM)-Screen-Japan 01: A Mutation Profiling Multicenter Study of Patients with AML

    Kenichi Miyamoto, Kentaro Fukushima, SungGi Chi, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Takanobu Morishita, Masamitsu Yanada, Kazuhito Yamamoto, Naohito Fujishima, Naoto Takahashi, Reiki Ogasawara, Takeshi Kondo, Yoshikazu Utsu, Nobuyuki Aotsuka, Kensuke Usuki, Takaaki Ono, Tsutomu Kobayashi, Junya Kuroda, Hiroto Horiguchi, Satoshi Iyama, Suguru Fukuhara, Koji Izutsu, Makoto Nakamura, Kensuke Kojima, Yosuke Minami

    BLOOD   136   2020.11

     More details

  • Successful brentuximab vedotin monotherapy against late relapse of classical Hodgkin lymphoma 6 years after first remission

    Kana Nagashima, Shohei Kikuchi, Satoshi Iyama, Chisa Fujita, Akari Goto, Hiroto Horiguchi, Masayoshi Kobune

    CLINICAL CASE REPORTS   8 ( 3 )   466 - 468   2020.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1002/ccr3.2688

    Web of Science

    researchmap

  • EPO-R plus myelodysplastic cells with ring sideroblasts produce high erythroferrone levels to reduce hepcidin expression in hepatic cells

    Shogo Miura, Masayoshi Kobune, Hiroto Horiguchi, Shohei Kikuchi, Satoshi Iyama, Kazuyuki Murase, Akari Goto, Hiroshi Ikeda, Kohichi Takada, Koji Miyanishi, Junji Kato

    BLOOD CELLS MOLECULES AND DISEASES   78   1 - 8   2019.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.bcmd.2019.04.014

    Web of Science

    researchmap

  • miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells

    Masahiro Yoshida, Hiroto Horiguchi, Shohei Kikuchi, Satoshi Iyama, Hiroshi Ikeda, Akari Goto, Yutaka Kawano, Kazuyuki Murase, Kohichi Takada, Koji Miyanishi, Junji Kato, Masayoshi Kobune

    PLOS ONE   14 ( 3 )   2019.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0213220

    Web of Science

    researchmap

  • Deletion of Murine <i>Rhoh</i> induces More Aggressive Diffuse Large B Cell Lymphoma (DLBCL) Via Interaction with Kaiso and Regulation of BCL-6 Expression

    Hiroto Horiguchi, Marioara Felicia Ciuculescu, Anja Troeger, Haiming Xu, Christian Brendel, David A. Williams

    BLOOD   132   2018.11

     More details

  • Extravesicular Mir-7977 Released from Leukemic Cells Inhibites the PCBP1-Mediated mRNA Stabilization and Hippo-YAP Signaling Pathway in Bone Marrow Mesenchymal Stromal Cells

    Masahiro Yoshida, Satoshi Iyama, Hiroto Horiguchi, Akari Goto, Shohei Kikuchi, Kazuyuki Murase, Kohichi Takada, Koji Miyanishi, Hiroshi Ikeda, Masahiro Maeda, Junji Kato, Masayoshi Kobune

    BLOOD   132   2018.11

     More details

  • Deletion of <i>Rhoh</i> Accelerates Development of Diffuse Large B Cell Lymphoma in <i>Bcl-6</i> Transgenic Mouse Model

    Hiroto Horiguchi, Marioara Felicia Ciuculescu, Christian Brendel, David A. Williams

    BLOOD   130   2017.12

     More details

    Language:English  

    Web of Science

    researchmap

  • Extracellular Vesicle microRNAs from Acute Myeloid Leukemia Are Involved in the Regulation of Adherence Junction in Bone Marrow Microenvironment.

    Masahiro Yoshida, Masayoshi Kobune, Shogo Miura, Soushi Ibata, Satoshi Iyama, Tsutomu Sato, Kazuyuki Murase, Kohichi Takada, Kaoru Ono, Akari Hashimoto, Ayumi Tatekoshi, Yusuke Kamihara, Yusuke Sugama, Shohei Kikuchi, Hiroshi Ikeda, Hiroto Horiguchi, Yutaka Kawano, Koji Miyanishi, Hiroyuki Kuroda, Masahiro Maeda, Junji Kato

    BLOOD   128 ( 22 )   2016.12

     More details

  • CD34/EPO-R Double Positive MDS Cells Produce Erythroferrone in Response to Erythropoietin

    Shogo Miura, Masayoshi Kobune, Soushi Ibata, Masahiro Yoshida, Satoshi Iyama, Tsutomu Sato, Kazuyuki Murase, Kohichi Takada, Kaoru Ono, Akari Hashimoto, Ayumi Tatekoshi, Yusuke Kamihara, Yusuke Sugama, Wataru Jomen, Shohei Kikuchi, Hiroshi Ikeda, Hiroto Horiguchi, Yutaka Kawano, Koji Miyanishi, Hiroyuki Kuroda, Masahiro Maeda, Junji Kato

    BLOOD   128 ( 22 )   2016.12

     More details

  • A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma

    Soushi Ibata, Tsutomu Sato, Hiroyuki Kuroda, Yasuhiro Nagamachi, Satoshi Iyama, Akihito Fujimi, Yusuke Kamihara, Yuichi Konuma, Masahiro Yoshida, Ayumi Tatekoshi, Akari Hashimoto, Hiroto Horiguchi, Kaoru Ono, Kazuyuki Murase, Kohichi Takada, Koji Miyanishi, Masayoshi Kobune, Yasuo Hirayama, Junji Kato

    CANCER CHEMOTHERAPY AND PHARMACOLOGY   78 ( 5 )   1041 - 1049   2016.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s00280-016-3163-y

    Web of Science

    researchmap

  • Effect of clarithromycin add-on therapy for patients with lenalidomid-resistant multiple myeloma

    Shogo Miura, Hiroyuki Kuroda, Michiko Yamada, Ken Sato, Hiroto Horiguchi, Takanori Shibata, Naoki Uemura, Tomoyuki Abe, Shigeyuki Fujii, Masahiro Maeda, Junji Kato

    ANNALS OF ONCOLOGY   27   2016.7

     More details

    Language:English  

    Web of Science

    researchmap

  • Significance of upper and lower gastrointestinal endoscopy during small intestinal screening in non-Hodgkin's lymphoma

    Ken Sato, Hiroyuki Kuroda, Shogo Miura, Hiroto Horiguchi, Takanori Shibata, Naoki Uemura, Tomoyuki Abe, Shigeyuki Fujii, Masahiro Maeda, Junji Kato

    ANNALS OF ONCOLOGY   27   2016.7

     More details

    Language:English  

    Web of Science

    researchmap

  • Isoform D of vascular endothelial growth factor in systemic capillary leak syndrome: a case report. International journal

    Soushi Ibata, Tsutomu Sato, Kohichi Takada, Ayumi Tatekoshi, Akari Hashimoto, Yusuke Kamihara, Wataru Jomen, Hiroto Horiguchi, Kaoru Ono, Kazuyuki Murase, Satoshi Iyama, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Junji Kato

    Journal of medical case reports   10   125 - 125   2016.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Systemic capillary leak syndrome is a rare condition characterized by episodic attacks of hypovolemia due to systemic capillary hyperpermeability, which results in profound hypotension and edema. Although the implication of vascular endothelial growth factor, angiopoietin-2, and C-X-C motif chemokine 10 has been suggested, the pathogenesis of systemic capillary leak syndrome remains unclear. In this report, we describe a case of systemic capillary leak syndrome in which serum isoform D of vascular endothelial growth factor was elevated. To the best of our knowledge, this is the first reported case of systemic capillary leak syndrome in which isoform D of vascular endothelial growth factor is suggested as the plausible biomarker. CASE PRESENTATION: A 41-year-old Japanese man was transferred to our emergency department. He was hypotensive, tachycardic, and edematous over the trunk and all four limbs. He received aggressive intravenous fluid therapy and underwent fasciotomy of the right forearm to prevent muscle necrosis. A diagnosis of systemic capillary leak syndrome was suspected. The presence of serum monoclonal immunoglobulin G and κ light chain supported this diagnosis. Prevention of hypotensive crises was unsuccessfully attempted with theophylline, intravenous immunoglobulin, high-dose dexamethasone, bortezomib, melphalan, and prednisolone; however, the patient's attacks dramatically disappeared after the introduction of thalidomide. The serum of the patient was stored soon after the onset of hypotensive crisis and analyzed to profile possible mediators responsible for the capillary leak. The concentration of vascular endothelial growth factor, angiopoietin-2, and C-X-C motif chemokine 10 were all within normal ranges. Meanwhile, we found that isoform D of vascular endothelial growth factor was elevated, which was normalized after the introduction of thalidomide. CONCLUSIONS: In our patient, isoform D of vascular endothelial growth factor (instead of vascular endothelial growth factor) may have been a causative factor of hypotensive crises, since isoform D contributes to vascular endothelial growth factor receptor-2 signaling, which is the major mediator of the permeability-enhancing effects of vascular endothelial growth factor. We suggest the measurement of isoform D of vascular endothelial growth factor in patients with systemic capillary leak syndrome in whose serum vascular endothelial growth factor is not elevated.

    DOI: 10.1186/s13256-016-0894-7

    PubMed

    researchmap

  • Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms

    Hiroto Horiguchi, Masayoshi Kobune, Shohei Kikuchi, Masahiro Yoshida, Masaki Murata, Kazuyuki Murase, Satoshi Iyama, Kohichi Takada, Tsutomu Sato, Kaoru Ono, Akari Hashimoto, Ayumi Tatekoshi, Yusuke Kamihara, Yutaka Kawano, Koji Miyanishi, Norimasa Sawada, Junji Kato

    HAEMATOLOGICA   101 ( 4 )   437 - 447   2016.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.3324/haematol.2015.134932

    Web of Science

    researchmap

  • Narrow-Band Ultraviolet B Phototherapy Ameliorates Acute Graft-Versus-Host Disease of the Intestine by Expansion of Regulatory T Cells

    Akari Hashimoto, Tsutomu Sato, Satoshi Iyama, Masahiro Yoshida, Soushi Ibata, Ayumi Tatekoshi, Yusuke Kamihara, Hiroto Horiguchi, Kazuyuki Murase, Yutaka Kawano, Kohichi Takada, Koji Miyanishi, Masayoshi Kobune, Shingo Ichimiya, Junji Kato

    PLOS ONE   11 ( 3 )   2016.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1371/journal.pone.0152823

    Web of Science

    researchmap

  • Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial

    Yasuo Hirayama, Kunihiko Ishitani, Yasushi Sato, Satoshi Iyama, Kohichi Takada, Kazuyuki Murase, Hiroyuki Kuroda, Yasuhiro Nagamachi, Yuichi Konuma, Akihito Fujimi, Tamotsu Sagawa, Kaoru Ono, Hiroto Horiguchi, Takeshi Terui, Kazuhiko Koike, Toshiro Kusakabe, Tsutomu Sato, Rishu Takimoto, Masayoshi Kobune, Junji Kato

    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY   20 ( 5 )   866 - 871   2015.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s10147-015-0810-y

    Web of Science

    researchmap

  • Exosomes Derived from AML/MDS Cells Is Involved in Stromal Dysfunction and Bone Marrow Failure

    Hiroto Horiguchi, Masayoshi Kobune, Shohei Kikuchi, Wataru Jomen, Kazuyuki Murase, Soushi Ibata, Satoshi Iyama, Tsutomu Sato, Yusuke Kamihara, Koji Miyanishi, Yasushi Sato, Tsuyoshi Hayashi, Rishu Takimoto, Junji Kato

    BLOOD   124 ( 21 )   2014.12

     More details

  • A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies

    Toshiro Sakai, Kyuhei Kohda, Yuichi Konuma, Yasuko Hiraoka, Yukari Ichikawa, Kaoru Ono, Hiroto Horiguchi, Ayumi Tatekoshi, Kouichi Takada, Satoshi Iyama, Junji Kato

    INTERNATIONAL JOURNAL OF HEMATOLOGY   100 ( 6 )   592 - 598   2014.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-014-1677-9

    Web of Science

    researchmap

  • [Markers of bone metabolism in multiple myeloma patients switched from zoledronic acid to denosumab].

    Ayumi Tatekoshi, Tsutomu Sato, Soushi Ibata, Akari Hashimoto, Yusuke Kamihara, Hiroto Horiguchi, Kaoru Ono, Kohichi Takada, Satoshi Iyama, Rishu Takimoto, Masayoshi Kobune, Junji Kato

    [Rinsho ketsueki] The Japanese journal of clinical hematology   55 ( 11 )   2271 - 6   2014.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    To date, intravenous drip infusion of zoledronic acid (ZA) has mainly been used for the treatment and prevention of skeletal-related events (SRE) in patients with multiple myeloma (MM). Recently, denosumab, a fully humanized monoclonal antibody against receptor activator of nuclear factor-κB ligand (RANKL), has also become available for the same purpose, but little is known about the impact of switching from ZA to denosumab. Herein, we present a retrospective study on bone metabolic markers in 10 MM patients initially treated with ZA and then switched to denosumab. Consequently, the levels of bone resorption markers, tartrate-resistant acid phosphatase 5b (TRACP-5b) and serum type-I collagen crosslinked N-telopeptide (sNTX), significantly decreased after denosumab treatment, while the levels of bone formation markers, osteocalcin (OC) and bone-specific alkaline phosphatase (BAP), showed no apparent changes. No patient developed severe hypocalcemia with denosumab treatment. In one patient not given chemotherapy, the M-protein level increased after switching from ZA to denosumab and plateaued when ZA was restarted. Based on this finding, we anticipate that switching from ZA to denosumab would exert a stronger suppressive effect on osteoclasts, but the anti-myeloma activity of ZA must be taken into consideration.

    PubMed

    researchmap

  • RADIATION-INDUCED LEIOMYOSARCOMA IN PROSTATE AFTER BRACHYTHERAPY FOR PROSTATIC ADENOCARCINOMA

    Hiroto Horiguchi, Kohichi Takada, Rishu Takimoto, Satoshi Iyama, Tsutomu Sato, Yasuo Hirayama, Toshifumi Hoki, Naoya Masumori, Tadashi Hasegawa, Junji Kato

    ANNALS OF ONCOLOGY   25   2014.10

     More details

    Language:English  

    Web of Science

    researchmap

  • EFFECT OF DULOXETINE ON PAINFUL CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY

    Yasuo Hirayama, Takeshi Terui, Toshiro Kusakabe, Hiroto Horiguchi, Kaoru Ono, Kazuhiko Koike, Junji Kato, Kunihiko Ishitani

    ANNALS OF ONCOLOGY   25   2014.10

     More details

  • [Effective treatment of metastatic rhabdomyosarcoma with pazopanib].

    Akari Hashimoto, Kohichi Takada, Rishu Takimoto, Hiroto Horiguchi, Tsutomu Sato, Satoshi Iyama, Kazuyuki Murase, Kaoru Ono, Ayumi Tatekoshi, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Masayoshi Kobune, Yasuo Hirayama, Hiroshi Kitamura, Katsuya Nakanishi, Naoya Masumori, Tadashi Hasegawa, Junji Kato

    Gan to kagaku ryoho. Cancer & chemotherapy   41 ( 8 )   1041 - 4   2014.8

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Pazopanib, an oral tyrosine kinase inhibitor, is the first molecular-targeted agent approved for the treatment of advanced soft tissue sarcoma(STS). Rhabdomyosarcoma in adults is rare, accounting for less than 3%of all adult STS cases. A 57-year old woman presented with cervical lymphadenopathy. Computed tomography revealed a heterogeneous mass in the retroperitoneum, replacing the entire right kidney. On the basis of the above findings, the patient was diagnosed with alveolar rhabdomyosarcoma. She was first treated with 4 courses of vincristine, actinomycin D, and cyclophosphamide(VAC), which resulted in a partial response. Dose reduction and delay occurred owing to hematological toxicity and febrile neutropenia. As second-line chemotherapy, the patient was administered a single daily dose of 800 mg of pazopanib. Because of an episode of hand-foot syndrome and hepatic impairment, the 800-mg daily dose of pazopanib was reduced to a daily dose of 600 mg, which had to be further reduced to a daily dose of 400 mg owing to fatigue and anorexia. The patient maintained a partial response for a total of 4.3 months when treated with pazopanib. Therefore, this drug may be a new treatment option for patients showing metastatic STS after previous chemotherapy.

    PubMed

    researchmap

  • Clinical utility of capsule endoscopy with flexible spectral imaging color enhancement for diagnosis of small bowel lesions

    Yasushi Sato, Tamotsu Sagawa, Masahiro Hirakawa, Hiroyuki Ohnuma, Takahiro Osuga, Yutaka Okagawa, Fumito Tamura, Hiroto Horiguchi, Kohichi Takada, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Rishu Takimoto, Masayoshi Kobune, Junji Kato

    ENDOSCOPY INTERNATIONAL OPEN   2 ( 2 )   E80 - E87   2014.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1055/s-0034-1365526

    Web of Science

    researchmap

  • Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+regulatory T cells

    Satoshi Iyama, Kazuyuki Murase, Tsutomu Sato, Akari Hashimoto, Ayumi Tatekoshi, Hiroto Horiguchi, Yusuke Kamihara, Kaoru Ono, Shohei Kikuchi, Kohichi Takada, Yutaka Kawano, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Satoru Mori, Junji Kato, Toshiharu Yamashita, Junji Kato

    INTERNATIONAL JOURNAL OF HEMATOLOGY   99 ( 4 )   471 - 476   2014.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-014-1530-1

    Web of Science

    researchmap

  • Combination Chemotherapy of Azacitidine and Cetuximab for Therapy-Related Acute Myeloid Leukemia following Oxaliplatin for Metastatic Colorectal Cancer

    Akari Hashimoto, Kohichi Takada, Hiroto Horiguchi, Tsutomu Sato, Satoshi Iyama, Kazuyuki Murase, Yusuke Kamihara, Kaoru Ono, Ayumi Tatekoshi, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Tomohisa Furuhata, Masayoshi Kobune, Rishu Takimoto, Koichi Hirata, Junji Kato

    CASE REPORTS IN ONCOLOGY   7 ( 2 )   316 - 322   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000363100

    Web of Science

    researchmap

  • Radiation-Induced Leiomyosarcoma of the Prostate after Brachytherapy for Prostatic Adenocarcinoma

    Hiroto Horiguchi, Kohichi Takada, Yusuke Kamihara, Soushi Ibata, Satoshi Iyama, Tsutomu Sato, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Ko Kobayashib, Yasuo Hirayama, Naoya Masumori, Tadashi Hasegawa, Junji Kato

    CASE REPORTS IN ONCOLOGY   7 ( 2 )   565 - 570   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000366294

    Web of Science

    researchmap

  • Efficacy of Enteral Supplementation Enriched with Glutamine, Fiber, and Oligosaccharide on Mucosal Injury following Hematopoietic Stem Cell Transplantation

    Satoshi Iyama, Tsutomu Sato, Hiroomi Tatsumi, Akari Hashimoto, Ayumi Tatekoshi, Yusuke Kamihara, Hiroto Horiguchi, Soushi Ibata, Kaoru Ono, Kazuyuki Murase, Kohichi Takada, Yasushi Sato, Tsuyoshi Hayashi, Koji Miyanishi, Emi Akizuki, Takayuki Nobuoka, Toru Mizugichi, Rishu Takimoto, Masayoshi Kobune, Koichi Hirata, Junji Kato

    CASE REPORTS IN ONCOLOGY   7 ( 3 )   692 - 699   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1159/000368714

    Web of Science

    researchmap

  • Myelodysplastic Syndrome-Derived Stromal Cells Support Leukemia-Initiating Cells and Contradirectly Eliminate Normal CD34+Clonogenic Cells

    Hiroto Horiguchi, Masayoshi Kobune, Shohei Kikuchi, Satoshi Iyama, Kohichi Takada, Kazuyuki Murase, Kaoru Ono, Yusuke Kamihara, Akari Hashimoto, Ayumi Tatekoshi, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Junji Kato

    BLOOD   122 ( 21 )   2013.11

     More details

  • Iron Chelation Therapy Could Rapidly Reduce Oxidative DNA Damage In CD34+Hematopoietic Cells Before Decrease Of Serum Ferritin Level

    Masayoshi Kobune, Shohei Kikuchi, Satoshi Iyama, Kohichi Takada, Kazuyuki Murase, Kaoru Ono, Hiroto Horiguchi, Yusuke Kamihara, Akari Hashimoto, Ayumi Tatekoshi, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Junji Kato

    BLOOD   122 ( 21 )   2013.11

     More details

  • [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].

    Kaoru Ono, Tsutomu Sato, Satoshi Iyama, Ayumi Tatekoshi, Akari Hashimoto, Yusuke Kamihara, Hiroto Horiguchi, Shohei Kikuchi, Kohichi Takada, Tsuyoshi Hayashi, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Masayoshi Kobune, Junji Kato

    [Rinsho ketsueki] The Japanese journal of clinical hematology   54 ( 11 )   2053 - 5   2013.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    The evidence that rituximab is effective therapy for refractory warm or cold autoimmune hemolytic anemia (AIHA) has been accumulating; however, the efficacy of rituximab for mixed-type AIHA is not evident. Herein, we report a case of mixed-type AIHA refractory to corticosteroids and splenectomy, but successfully treated with rituximab (375 mg/m(2)/day, once weekly, four times). She achieved a complete response, which has been maintained for 16 months, to date, despite steroid tapering. Our case suggests that rituximab therapy should be considered for refractory AIHA even of mixed-type.

    PubMed

    researchmap

  • IRON CHELATION THERAPY IMPROVES OXIDATIVE DNA DAMAGE IN HEMATOPOIETIC CELLS DERIVED FROM TRANSFUSION-DEPENDENT MYELODYSPLASTIC SYNDROME

    Masayoshi Kobune, Shohei Kikuchi, Satoshi Iyama, Kohichi Takada, Kazuyuki Murase, Kaoru Ono, Hiroto Horiguchi, Yusuke Kamihara, Tsuyoshi Hayashi, Tsutomu Sato, Koji Miyanishi, Yasushi Sato, Rishu Takimoto, Junji Kato

    AMERICAN JOURNAL OF HEMATOLOGY   88 ( 5 )   E98 - E98   2013.5

     More details

    Language:English  

    Web of Science

    researchmap

  • Clinical Usefulness of Capsule Endoscopy With Flexible Spectral Imaging Color Enhancement for Diagnosis of Small Bowel Lesions

    Tamotsu Sagawa, Yasushi Sato, Hiroyuki Ohnuma, Yasuhiro Sato, Hiroto Horiguchi, Tokiko Nakamura, Koshi Fujikawa, Yasuo Takahashi, Masayoshi Kobune, Rishu Takimoto, Hidetoshi Ohta, Michiaki Hirayama, Shinichi Katsuki, Junji Kato

    GASTROINTESTINAL ENDOSCOPY   75 ( 4 )   252 - 252   2012.4

     More details

    Language:English  

    Web of Science

    researchmap

▼display all

Research Projects

  • 骨髄微細環境における神経-白血病系の解析

    Grant number:24K11546  2024.4 - 2027.3

    日本学術振興会  科学研究費助成事業  基盤研究(C)

    堀口 拓人, 後藤 亜香利, 小船 雅義

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    髄内神経システムが正常造血及び造血障害に関与することが見出されつつあり、シナプス小胞内の神経ペプチドが造血幹細胞維持に関与することが報告された。しかしながら、神経-造血幹細胞系に関して報告されているものの、神経-白血病系については未だ報告はない。
    神経ペプチドであるTuberoinfundibular peptide of 39 residues (TIP39)の受容体であるParathyroid hormone(PTH)2受容体 (PTH2R) の高発現が急性骨髄性白血病(AML)の予後不良であることを見出したが、その機能は不明であった。申請者は、TIP39を添加してAML細胞株を培養したところ、オートファジーが誘導されることを見出した。このため本研究では、神経ペプチドであるTIP39によりAML細胞株で誘導されたオートファジーの細胞内シグナル伝達などの詳細な解析、造血器腫瘍であるAMLにおけるTIP39誘導オートファジーの役割、骨髄微細環境内のTIP39産生細胞を同定、そして正常骨髄微細環境との比較により、AMLの新たな治療標的としての可能性を模索することを目指すものである。

    researchmap

  • Development of new therapy for AML by targeting of neuropeptide-PTH2R system

    Grant number:22K08509  2022.4 - 2025.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Kobune Masayoshi

      More details

    Grant amount:\4160000 ( Direct Cost: \3200000 、 Indirect Cost:\960000 )

    Analysis of public GEO datasets (GSE58831, GSE24395) demonstrated that PTH2R is markedly up-regulated in the CD34+CD38-leukemia stem-cell compartment of acute myeloid leukemia (AML) patients. High PTH2R expression correlated with inferior overall survival and retained prognostic significance independently of cytogenetic risk and gene-mutation status. In hematopoietic tumor cell lines, stimulation of the TIP39-PTH2R axis induced autophagy, evidenced by LC3-II accumulation, while concomitantly suppressing caspase-3-dependent apoptosis. Autophagic activation was accompanied by reduced phosphorylation of mTOR, and knock-down of PTH2R by siRNA abrogated this survival advantage, confirming receptor dependence. Collectively, these data identify the TIP39-PTH2R pathway as a critical regulator of AML stem-cell survival and highlight it as a promising molecular target for therapeutic intervention.

    researchmap

  • Function of neuropeptide, TIP39, in bone marrow microenvironment with hematopoietic neoplasm

    Grant number:21K16273  2021.4 - 2023.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Early-Career Scientists

    HORIGUCHI HIROTO

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    First, we analyzed proliferation of AML cell lines under TIP39 stimulation. The difference has not observed between culture with TIP39 and without TIP39.
    Next, we conducted AML cell culture without serum, in starved condition, to research the effect to survival of AML cell. Surprisingly, TIP39-stimulated AML cells were significantly survival under starved condition. Moreover, increased LC3-II expression in TIP39-stimulated AML cell at one to two hours after the stimulation was observed compared to unstimulated AML cell by western blot analysis. In addition, under normal culture the increased LC3-II was also revealed in the stimulated cells. Furthermore, the proportion of apoptosis in TIP39-stimulated AML cell was decreased compared to unstimulated AML cell. These results suggest that TIP39-induced autophagy could affect survival advantage over normal cell.

    researchmap

  • Role of KAISO and P120 complex in lymphoid leukemia

    Grant number:19K23921  2019.8 - 2021.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Research Activity Start-up

    Horiguchi Hiroto

      More details

    Grant amount:\2860000 ( Direct Cost: \2200000 、 Indirect Cost:\660000 )

    We purchased acute leukemia cell lines (BALL-1, HAL-01, NALM-6, TALL, MOLT-4, and Jurkat). They were cultured and their RNAs were extracted by using TRIzol.
    Reverse transcription quantitative polymerase chain reaction (RT-qPCR) revealed that KAISO mRNAs of BALL-1 and HAL-01 were significantly decreased than normal B cell and KAISO mRNAs of TALL, MOLT-4, and Jurkat were significantly decreased than normal T cell. Moreover, Catenin delta-1 mRNAs of all B cell leukemia lines and T cell leukemia cell lines were significantly decreased than normal B cell and T cell, respectively.

    researchmap

  • The effect of exosomal miRNA on AML/MDS stromal cells

    Grant number:15K09482  2015.4 - 2018.3

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Kobune Masayoshi

      More details

    Grant amount:\4940000 ( Direct Cost: \3800000 、 Indirect Cost:\1140000 )

    The failure of normal hematopoiesis is observed in myeloid neoplasms. However, the precise mechanisms governing replacement of normal hematopoietic stem cells in their niche by myeloid neoplasm stem cells have not been clarified yet. Primary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) cells induced aberrant expression of multiple hematopoietic factors including JAG1, SCF and ANGPT1 in mesenchymal stem cells. Importantly, transfer of myeloid neoplasm-derived extracellular vesicles reduced the hematopoietic-supportive capacity of mesenchymal stem cells. Analysis of exosomal microRNA indicated that several species including miR-7977 from acute myeloid leukemia cells were higher than those from normal CD34+ cells. Remarkably, the copy number of miR-7977 in BM interstitial fluid was elevated in not only AML, but also MDS, as compared with control bone marrow. Thus, miR-7977 in extracellular vesicles may be a critical factor that induces failure of normal hematopoiesis.

    researchmap